Rewalk Robotics (NASDAQ:RWLK) announced its quarterly earnings data on Thursday. The medical device company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.01, Morningstar.com reports. Rewalk Robotics had a negative return on equity of 3,654.32% and a negative net margin of 365.87%. The company had revenue of $1.62 million during the quarter, compared to the consensus estimate of $2.12 million. Rewalk Robotics updated its FY 2018 guidance to EPS.

Shares of RWLK remained flat at $$0.67 during mid-day trading on Friday. The stock had a trading volume of 433,778 shares, compared to its average volume of 191,463. The stock has a market capitalization of $25.92 million, a price-to-earnings ratio of -0.68 and a beta of 0.77. Rewalk Robotics has a one year low of $0.65 and a one year high of $1.60.

A number of analysts have recently issued reports on RWLK shares. Zacks Investment Research upgraded Rewalk Robotics from a “hold” rating to a “buy” rating and set a $1.25 target price for the company in a report on Thursday, August 30th. Oppenheimer restated a “buy” rating on shares of Rewalk Robotics in a report on Monday, July 23rd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $1.85.

TRADEMARK VIOLATION WARNING: “Rewalk Robotics (RWLK) Releases Earnings Results, Beats Expectations By $0.01 EPS” was originally reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.dailypolitical.com/2018/11/10/rewalk-robotics-rwlk-releases-earnings-results-beats-expectations-by-0-01-eps.html.

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Further Reading: What are trading strategies for the 52-week high/low?

Earnings History for Rewalk Robotics (NASDAQ:RWLK)

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.